75 related articles for article (PubMed ID: 14519636)
1. p15INK4b, p14ARF, and p16INK4a inactivation in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors.
Perrone F; Tabano S; Colombo F; Dagrada G; Birindelli S; Gronchi A; Colecchia M; Pierotti MA; Pilotti S
Clin Cancer Res; 2003 Sep; 9(11):4132-8. PubMed ID: 14519636
[TBL] [Abstract][Full Text] [Related]
2. Deletions of the INK4A gene occur in malignant peripheral nerve sheath tumors but not in neurofibromas.
Kourea HP; Orlow I; Scheithauer BW; Cordon-Cardo C; Woodruff JM
Am J Pathol; 1999 Dec; 155(6):1855-60. PubMed ID: 10595915
[TBL] [Abstract][Full Text] [Related]
3. Malignant peripheral nerve sheath tumors.
Farid M; Demicco EG; Garcia R; Ahn L; Merola PR; Cioffi A; Maki RG
Oncologist; 2014 Feb; 19(2):193-201. PubMed ID: 24470531
[TBL] [Abstract][Full Text] [Related]
4. Breast Cancer and p16: Role in Proliferation, Malignant Transformation and Progression.
Jovanovic DV; Mitrovic SL; Milosavljevic MZ; Ilic MB; Stankovic VD; Vuletic MS; Dimitrijevic Stojanovic MN; Milosev DB; Azanjac GL; Nedeljkovic VM; Radovanovic D
Healthcare (Basel); 2021 Sep; 9(9):. PubMed ID: 34575014
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of MEK inhibition in a recurrent malignant peripheral nerve sheath tumor.
Nagabushan S; Lau LMS; Barahona P; Wong M; Sherstyuk A; Marshall GM; Tyrrell V; Wegner EA; Ekert PG; Cowley MJ; Mayoh C; Trahair TN; Crowe P; Anazodo A; Ziegler DS
NPJ Precis Oncol; 2021 Feb; 5(1):9. PubMed ID: 33580196
[TBL] [Abstract][Full Text] [Related]
6. Molecular targets for NF1-associated malignant peripheral nerve sheath tumor.
Binobaid L; Masternak MM
Rep Pract Oncol Radiother; 2020; 25(4):556-561. PubMed ID: 32494228
[TBL] [Abstract][Full Text] [Related]
7. CDKs in Sarcoma: Mediators of Disease and Emerging Therapeutic Targets.
Kohlmeyer JL; Gordon DJ; Tanas MR; Monga V; Dodd RD; Quelle DE
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32344731
[TBL] [Abstract][Full Text] [Related]
8. Aberrant expression of p16
Inoue K; Fry EA
Cancer Rep Rev; 2018 Mar; 2(2):. PubMed ID: 29951643
[TBL] [Abstract][Full Text] [Related]
9. NF1
Dodd RD; Lee CL; Overton T; Huang W; Eward WC; Luo L; Ma Y; Ingram DR; Torres KE; Cardona DM; Lazar AJ; Kirsch DG
Cancer Res; 2017 Aug; 77(16):4486-4497. PubMed ID: 28646022
[TBL] [Abstract][Full Text] [Related]
10. Telomere erosion in NF1 tumorigenesis.
Jones RE; Grimstead JW; Sedani A; Baird D; Upadhyaya M
Oncotarget; 2017 Jun; 8(25):40132-40139. PubMed ID: 28454108
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic mechanisms drive the progression of neurofibromas to malignant peripheral nerve sheath tumors.
Suresh K; Kliot T; Piunti A; Kliot M
Surg Neurol Int; 2016; 7(Suppl 33):S797-S800. PubMed ID: 27920939
[TBL] [Abstract][Full Text] [Related]
12. Whole Exome Sequencing Reveals the Order of Genetic Changes during Malignant Transformation and Metastasis in a Single Patient with NF1-plexiform Neurofibroma.
Hirbe AC; Dahiya S; Miller CA; Li T; Fulton RS; Zhang X; McDonald S; DeSchryver K; Duncavage EJ; Walrath J; Reilly KM; Abel HJ; Pekmezci M; Perry A; Ley TJ; Gutmann DH
Clin Cancer Res; 2015 Sep; 21(18):4201-11. PubMed ID: 25925892
[TBL] [Abstract][Full Text] [Related]
13. PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors.
Lee W; Teckie S; Wiesner T; Ran L; Prieto Granada CN; Lin M; Zhu S; Cao Z; Liang Y; Sboner A; Tap WD; Fletcher JA; Huberman KH; Qin LX; Viale A; Singer S; Zheng D; Berger MF; Chen Y; Antonescu CR; Chi P
Nat Genet; 2014 Nov; 46(11):1227-32. PubMed ID: 25240281
[TBL] [Abstract][Full Text] [Related]
14. Methylated RASSF1A in malignant peripheral nerve sheath tumors identifies neurofibromatosis type 1 patients with inferior prognosis.
Danielsen SA; Lind GE; Kolberg M; Høland M; Bjerkehagen B; Sundby Hall K; van den Berg E; Mertens F; Smeland S; Picci P; Lothe RA
Neuro Oncol; 2015 Jan; 17(1):63-9. PubMed ID: 25038505
[TBL] [Abstract][Full Text] [Related]
15. Anthracycline-based chemotherapy in extraskeletal myxoid chondrosarcoma: a retrospective study.
Stacchiotti S; Dagrada GP; Sanfilippo R; Negri T; Vittimberga I; Ferrari S; Grosso F; Apice G; Tricomi M; Colombo C; Gronchi A; Dei Tos AP; Pilotti S; Casali PG
Clin Sarcoma Res; 2013 Dec; 3(1):16. PubMed ID: 24345066
[TBL] [Abstract][Full Text] [Related]
16. Preclinical therapeutic efficacy of a novel pharmacologic inducer of apoptosis in malignant peripheral nerve sheath tumors.
Chau V; Lim SK; Mo W; Liu C; Patel AJ; McKay RM; Wei S; Posner BA; De Brabander JK; Williams NS; Parada LF; Le LQ
Cancer Res; 2014 Jan; 74(2):586-97. PubMed ID: 24285727
[TBL] [Abstract][Full Text] [Related]
17. p14(ARF) methylation is a common event in the pathogenesis and progression of myxoid and pleomorphic liposarcoma.
Davidović R; Sopta J; Mandušić V; Krajnović M; Stanojević M; Tulić G; Dimitrijević B
Med Oncol; 2013; 30(3):682. PubMed ID: 23918242
[TBL] [Abstract][Full Text] [Related]
18. Transgenic mice overexpressing neuregulin-1 model neurofibroma-malignant peripheral nerve sheath tumor progression and implicate specific chromosomal copy number variations in tumorigenesis.
Kazmi SJ; Byer SJ; Eckert JM; Turk AN; Huijbregts RP; Brossier NM; Grizzle WE; Mikhail FM; Roth KA; Carroll SL
Am J Pathol; 2013 Mar; 182(3):646-67. PubMed ID: 23321323
[TBL] [Abstract][Full Text] [Related]
19. Non-coding RNA ANRIL and the number of plexiform neurofibromas in patients with NF1 microdeletions.
Mußotter T; Kluwe L; Högel J; Nguyen R; Cooper DN; Mautner VF; Kehrer-Sawatzki H
BMC Med Genet; 2012 Oct; 13():98. PubMed ID: 23101500
[TBL] [Abstract][Full Text] [Related]
20. p16(INK4a) and p15(INK4b) gene promoter methylation in cervical cancer patients.
Jha AK; Nikbakht M; Jain V; Capalash N; Kaur J
Oncol Lett; 2012 Jun; 3(6):1331-1335. PubMed ID: 22783444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
